148P Neoadjuvant EGFR-TKI combined with chemotherapy improves the complete response rate in operable EGFR-mutant NSCLC patients: A multicenter real-world study W. Yan, Z-R. Zhao,M. Fan, L. Dai, Y. Fang, X. Yang, H. Fu,K-N. ChenESMO Open（2024）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
